Annual EBITDA
$2.70B$82.00M+3.13%
Summary
- Current Value
- As of today, ALC annual EBITDA is $2.70B, up +3.13% on
- Historical Performance
- ALC annual EBITDA is up +28.22% over the past 3 years, up +67.74% over the past 5 years
- All-Time High Comparison
- ALC annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ALC annual EBITDA is +28.22% above its 3-year low of $2.11B reached on an earlier date
- Sector Comparison
- ALC annual EBITDA is higher than 96.04% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.70B | +3.1% | +28.2% | +67.7% | – | |
| Quarterly EBITDA | $703.00M | -11.1% | +15.8% | +40.9% | – | |
| TTM EBITDA | $2.73B | -0.0% | +19.3% | +75.5% | – | |
| Price | $66.28 | -25.8% | -19.0% | -2.0% | – | |
| PE Ratio | 39.98 | +0.7% | -66.4% | – | – | |
| Annual Revenue | $10.40B | +4.9% | +19.3% | +52.2% | – | |
| Annual EPS | $1.98 | -3.5% | +191.5% | +281.9% | +100.0% | |
| $1.36B | -1.8% | +38.9% | +9842.9% | +100.0% | ||
| Annual Net Income | $980.00M | -3.7% | +192.5% | +284.6% | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.70B | at high | |
| 5Y | $2.70B | at high | |
| All | $2.70B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.11B | N/A | +28.2% |
| 5Y | $1.61B | N/A | +67.7% |
| All | $1.23B | +119.8% |
EBITDA History
FAQ
What is the current annual EBITDA of ALC?
As of today, ALC annual EBITDA is $2.70B
What is 1-year change in ALC annual EBITDA?
ALC annual EBITDA is up +3.13% year-over-year
What is 3-year change in ALC annual EBITDA?
ALC annual EBITDA is up +28.22% over the past 3 years
How far is ALC annual EBITDA from its all-time high?
ALC annual EBITDA is currently at its all-time high
How does ALC annual EBITDA rank versus sector peers?
ALC annual EBITDA is higher than 96.04% of companies in Healthcare sector
When is ALC next annual earnings release?
As of today, the next annual earnings release for ALC has not been scheduled
Quarterly EBITDA
$703.00M$38.00M-5.13%
Summary
- Current Value
- As of today, ALC quarterly EBITDA is $703.00M, down -5.13% on
- Historical Performance
- ALC quarterly EBITDA is down -11.13% year-over-year, up +15.82% over the past 3 years
- All-Time High Comparison
- ALC quarterly EBITDA is currently -11.13% below its historical high of $791.00M set on
- 3-Year Low Comparison
- ALC quarterly EBITDA is +16.78% above its 3-year low of $602.00M reached on
- Sector Comparison
- ALC quarterly EBITDA is higher than 96.12% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $703.00M | -5.1% | -11.1% | +15.8% | +40.9% | |
| Annual EBITDA | $2.70B | – | +3.1% | +28.2% | +67.7% | |
| TTM EBITDA | $2.73B | -3.1% | -0.0% | +19.3% | +75.5% | |
| Price | $66.28 | -20.4% | -25.8% | -19.0% | -2.0% | |
| PE Ratio | 39.98 | -5.1% | +0.7% | -66.4% | – | |
| Quarterly Revenue | $2.71B | -0.4% | +9.4% | +15.1% | +40.2% | |
| Quarterly EPS | $0.39 | -12.5% | -45.1% | +9.8% | +126.2% | |
| $419.00M | +15.1% | -12.9% | +36.5% | +94.9% | ||
| Quarterly Net Income | $189.00M | -12.9% | -46.0% | +8.6% | +125.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $791.00M | N/A | -11.1% |
| 3Y | $791.00M | -11.1% | |
| 5Y | $791.00M | -11.1% | |
| All | $791.00M | -11.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $602.00M | +16.8% | |
| 3Y | $602.00M | +16.8% | |
| 5Y | $460.00M | +52.8% | |
| All | $71.00M | +890.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ALC?
As of today, ALC quarterly EBITDA is $703.00M
What is ALC quarterly EBITDA most recent change?
ALC quarterly EBITDA was down -5.13% on March 1, 2026
What is 1-year change in ALC quarterly EBITDA?
ALC quarterly EBITDA is down -11.13% year-over-year
How far is ALC quarterly EBITDA from its all-time high?
ALC quarterly EBITDA is currently -11.13% below its historical high of $791.00M set on March 31, 2025
How does ALC quarterly EBITDA rank versus sector peers?
ALC quarterly EBITDA is higher than 96.12% of companies in Healthcare sector
When is ALC next earnings release?
As of today, the next earnings release for ALC has not been scheduled
TTM EBITDA
$2.73B$88.00M-3.12%
Summary
- Current Value
- As of today, ALC TTM EBITDA is $2.73B, down -3.12% on
- Historical Performance
- ALC TTM EBITDA is down -0.04% year-over-year, up +19.31% over the past 3 years
- All-Time High Comparison
- ALC TTM EBITDA is currently -3.12% below its historical high of $2.82B set on
- 3-Year Low Comparison
- ALC TTM EBITDA is +19.31% above its 3-year low of $2.29B reached on an earlier date
- Sector Comparison
- ALC TTM EBITDA is higher than 95.94% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.73B | -3.1% | -0.0% | +19.3% | +75.5% | |
| Annual EBITDA | $2.70B | – | +3.1% | +28.2% | +67.7% | |
| Quarterly EBITDA | $703.00M | -5.1% | -11.1% | +15.8% | +40.9% | |
| Price | $66.28 | -20.4% | -25.8% | -19.0% | -2.0% | |
| PE Ratio | 39.98 | -5.1% | +0.7% | -66.4% | – | |
| TTM Revenue | $10.63B | +2.2% | +7.1% | +19.8% | +53.6% | |
| TTM EPS | $1.66 | -16.1% | -26.3% | +141.0% | +307.2% | |
| $1.42B | -4.2% | -4.7% | +25.9% | +1700.0% | ||
| TTM Net Income | $819.00M | -16.4% | -26.9% | +140.2% | +310.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.82B | -3.1% | |
| 3Y | $2.82B | -3.1% | |
| 5Y | $2.82B | -3.1% | |
| All | $2.82B | -3.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.70B | +1.2% | |
| 3Y | $2.29B | N/A | +19.3% |
| 5Y | $1.56B | N/A | +75.5% |
| All | $260.00M | +950.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ALC?
As of today, ALC TTM EBITDA is $2.73B
What is ALC TTM EBITDA most recent change?
ALC TTM EBITDA was down -3.12% on March 1, 2026
What is 1-year change in ALC TTM EBITDA?
ALC TTM EBITDA is down -0.04% year-over-year
How far is ALC TTM EBITDA from its all-time high?
ALC TTM EBITDA is currently -3.12% below its historical high of $2.82B set on December 1, 2025
How does ALC TTM EBITDA rank versus sector peers?
ALC TTM EBITDA is higher than 95.94% of companies in Healthcare sector
When is ALC next earnings release?
As of today, the next earnings release for ALC has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ALC Official Website www.alcon.com
- ALC Profile on Yahoo Finance finance.yahoo.com/quote/ALC
- ALC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alc